share_log

Allena Pharmaceuticals (ALNAQ) Set to Announce Earnings on Tuesday

Allena Pharmaceuticals (ALNAQ) Set to Announce Earnings on Tuesday

阿琳娜製藥（ALNAQ）將於週二宣布收益
Financial News Live ·  2022/11/07 23:01

Allena Pharmaceuticals (NASDAQ:ALNAQ – Get Rating) is set to announce its earnings results on Tuesday, November 8th.

阿琳娜製藥公司（NASDAQ：ALNAQ-獲取評級）將於 11 月 8 日（星期二）宣布其收益業績。

Allena Pharmaceuticals Stock Performance

阿琳娜製藥股票性能

Shares of Allena Pharmaceuticals stock remained flat at $0.01 on Monday. The stock had a trading volume of 363,247 shares, compared to its average volume of 12,972,626. The company's 50-day moving average is $0.02. Allena Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $1.00.

艾琳娜製藥股票的股票週一保持平穩 0.01 美元。該股的交易量為 363,247 股，與其平均成交量為 12,972,626 股相比。該公司的 50 天移動平均線為 0.02 美元。艾琳娜製藥有一個 12 月低點 0.01 美元和 12 個月高點 1.00 美元。

Get
取得
Allena Pharmaceuticals
阿琳娜药品
alerts:
警報：

About Allena Pharmaceuticals

關於阿琳娜製藥

(Get Rating)

(取得評分)

Allena Pharmaceuticals, Inc, a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease.
Allena Pharics, Inc. 是一家生物製藥公司，在美國發現、開發和商業化口服酶治療藥物，用於治療罕見和重度代謝和腎功能紊亂的患者。其主要候選產品是 ALLN-346，這是一種新穎的尿酸降解酶，用於治療晚期慢性腎臟疾病的高尿酸血症和痛風患者。

Read More

閱讀更多

  • Get a free copy of the StockNews.com research report on Allena Pharmaceuticals (ALNAQ)
  • Bulls Vs Bears: Mullen Automotive Short Interest Grows
  • Palantir Falls Into The Hands Of Value Investors
  • The Analysts Can't Keep Up with Arista Networks Stock
  • 3 Reasons Amazon Will Deliver Better 2023 Returns
  • A Turnaround is Brewing in Starbucks Stock
  • 獲取有關艾琳娜製藥公司（ALNAQ）的研究報告的免費副本
  • 牛市 VS 熊市：馬倫汽車短期利益增長
  • 帕蘭蒂爾落入價值投資者手中
  • 分析師無法跟上阿里斯塔網絡股票
  • 亞馬遜將提供 2023 年更好的退貨的 3 個原因
  • 星巴克股票正在醞釀周轉

Receive News & Ratings for Allena Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allena Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收 Allena 藥品的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Allena 製藥及相關公司的最新新聞和分析師評級的簡要每日摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論